SE503261C2 - Användning av 5-isopropyl-2'-beta-deoxyuridin för framställning av en komposition för utvärtes användning mot herpesvirus - Google Patents

Användning av 5-isopropyl-2'-beta-deoxyuridin för framställning av en komposition för utvärtes användning mot herpesvirus

Info

Publication number
SE503261C2
SE503261C2 SE8802193A SE8802193A SE503261C2 SE 503261 C2 SE503261 C2 SE 503261C2 SE 8802193 A SE8802193 A SE 8802193A SE 8802193 A SE8802193 A SE 8802193A SE 503261 C2 SE503261 C2 SE 503261C2
Authority
SE
Sweden
Prior art keywords
deoxyuridine
isopropyl
composition
skin
beta
Prior art date
Application number
SE8802193A
Other languages
English (en)
Swedish (sv)
Other versions
SE8802193D0 (sv
SE8802193L (sv
Inventor
Anna Szabolcs
Laszlo Oetvoes
Janos Sagi
Nee Feuer Helga Tuedoes
Attila Szemzoe
Zsuzsa Veres
Istvan Szinai
Miklos Vajda
Istvan Csernus
Katalin Marossy
Sandor Jancso
Nee Lukacs Eva Medgyesi
Gyoergy Bacsa
Original Assignee
Mta Koezponti Kemiai Kutato In
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mta Koezponti Kemiai Kutato In, Biogal Gyogyszergyar filed Critical Mta Koezponti Kemiai Kutato In
Publication of SE8802193D0 publication Critical patent/SE8802193D0/xx
Publication of SE8802193L publication Critical patent/SE8802193L/xx
Publication of SE503261C2 publication Critical patent/SE503261C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8802193A 1987-08-07 1988-06-13 Användning av 5-isopropyl-2'-beta-deoxyuridin för framställning av en komposition för utvärtes användning mot herpesvirus SE503261C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU873596A HU196038B (en) 1987-08-07 1987-08-07 Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine

Publications (3)

Publication Number Publication Date
SE8802193D0 SE8802193D0 (sv) 1988-06-13
SE8802193L SE8802193L (sv) 1989-02-08
SE503261C2 true SE503261C2 (sv) 1996-04-29

Family

ID=10964716

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8802193A SE503261C2 (sv) 1987-08-07 1988-06-13 Användning av 5-isopropyl-2'-beta-deoxyuridin för framställning av en komposition för utvärtes användning mot herpesvirus

Country Status (25)

Country Link
US (2) US4880785A (ja)
JP (1) JPS6442437A (ja)
KR (1) KR960015953B1 (ja)
CN (1) CN1034133A (ja)
AU (1) AU605875B2 (ja)
BE (1) BE1001774A4 (ja)
CA (1) CA1286227C (ja)
CH (1) CH675538A5 (ja)
CS (1) CS276467B6 (ja)
CY (1) CY1655A (ja)
DD (1) DD270656A5 (ja)
DE (1) DE3820270A1 (ja)
DK (1) DK299088A (ja)
ES (1) ES2010559A6 (ja)
FI (1) FI883692A (ja)
FR (1) FR2619010B1 (ja)
GB (1) GB2207864B (ja)
GR (1) GR1000139B (ja)
HU (1) HU196038B (ja)
IT (1) IT1217789B (ja)
NL (1) NL8801411A (ja)
NO (1) NO882491L (ja)
RU (1) RU2035180C1 (ja)
SE (1) SE503261C2 (ja)
SG (1) SG42292G (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
HUP9602024A3 (en) * 1996-07-25 1999-05-28 Toth Sandor Pharmaceutical composition containing aminoacid for external use
MY136633A (en) * 2001-01-17 2008-11-28 Berlin Chemie Ag Stabilized brivudine topical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2918260A1 (de) * 1979-05-07 1980-11-27 Robugen Gmbh Anwendung von 5-alkyl-2'-desoxyuridinen
DE3010397A1 (de) * 1980-03-18 1981-10-29 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen Verwendung von 5-alkyl-pyrimidinnukleosiden als cytostatika
EP0085084A1 (de) * 1981-08-04 1983-08-10 Robugen Gmbh Pharmazeutische Fabrik Kombinationspräparat mit synergistischer wirkung
HU198393B (en) * 1984-03-06 1989-10-30 Sloan Kettering Inst Cancer Process for production of medical composition suitable for treatment of hepatitis containing as active substance derivatives of piramidin-nucleoside
HU197837B (en) * 1984-12-29 1989-06-28 Mta Koezponti Kemiai Kutato In Composition with skin cleaning effect, particularly for treating pimpled skin of face

Also Published As

Publication number Publication date
IT8820871A0 (it) 1988-06-06
FR2619010B1 (fr) 1992-02-14
CH675538A5 (ja) 1990-10-15
FR2619010A1 (fr) 1989-02-10
FI883692A (fi) 1989-02-08
GR880100417A (en) 1989-05-25
KR890003380A (ko) 1989-04-14
AU1741388A (en) 1989-02-09
CA1286227C (en) 1991-07-16
US4880785A (en) 1989-11-14
DK299088D0 (da) 1988-06-02
CN1034133A (zh) 1989-07-26
SG42292G (en) 1992-09-04
FI883692A0 (fi) 1988-08-08
AU605875B2 (en) 1991-01-24
SE8802193D0 (sv) 1988-06-13
IT1217789B (it) 1990-03-30
JPH0515694B2 (ja) 1993-03-02
GB2207864B (en) 1992-01-15
NO882491D0 (no) 1988-06-06
CY1655A (en) 1993-05-14
JPS6442437A (en) 1989-02-14
GR1000139B (el) 1991-09-27
DK299088A (da) 1989-02-08
ES2010559A6 (es) 1989-11-16
NO882491L (no) 1989-02-08
BE1001774A4 (fr) 1990-03-06
US4937233A (en) 1990-06-26
SE8802193L (sv) 1989-02-08
DD270656A5 (de) 1989-08-09
GB2207864A (en) 1989-02-15
CS276467B6 (en) 1992-06-17
GB8813392D0 (en) 1988-07-13
DE3820270A1 (de) 1989-02-16
KR960015953B1 (ko) 1996-11-25
CS441388A3 (en) 1992-01-15
NL8801411A (nl) 1989-03-01
HU196038B (en) 1988-09-28
RU2035180C1 (ru) 1995-05-20

Similar Documents

Publication Publication Date Title
US5216142A (en) Anti-virals
JP4782365B2 (ja) ウイルス感染症と癌細胞を二重ターゲッティングする組成物及び方法
Maudgal et al. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis
JPH08510236A (ja) 局所使用のためのアシクロビル誘導体
Heidelberger et al. Trifluorothymidine
US4990537A (en) Anti influenza agent
JP2829440B2 (ja) Ｏ▲上６▼―アルキルグアニン―ｄｎａアルキルトランスフェラーゼ減少化活性を有するｏ▲上６▼―ベンジル化グアニン、グアノシンおよび２′―デオキシグアノシン化合物
DE69333699T2 (de) Pyrimidinnukleotid-vorläufer zur behandlung entzündlicher hepatitis
Georgian The comparative cytogenetic effects of aldrin and phosphamidon
SE503261C2 (sv) Användning av 5-isopropyl-2'-beta-deoxyuridin för framställning av en komposition för utvärtes användning mot herpesvirus
Vemo et al. Toxicity and reproductive parameters impairment of cypermethrin in male guinea pig (Cavia porcellus)
CN105311636B (zh) 一种抗疱疹病毒软膏剂及其制备方法
DE2411823A1 (de) Verwendung von 1,2,4-triazol-3-carboxamiden und -thiocarboxamiden als antivirenmittel
CA1302887C (en) Combination of acyclovir or a derivative thereof and bacitracin
DE60132581T2 (de) Medikament zur behandlung von durch parasitäre protozoen verursachte erkrankungen
CA2102518A1 (en) Antifungal agents
US7999099B2 (en) Modified 5′-phosphonate azidothymidine—potential anti-viral preparations
EP0082667A1 (en) Pharmaceutical compositions
EP1513539B1 (de) Verwendung von amphiphilen nucleosid-phosphonoameisensäure-derivaten zur behandlung von viralen infektionskrankheiten
McSharry et al. Arildone: a β-diketone
PesticideSci Technical Information
CA2489357A1 (en) Aryl phosphate derivatives with selective activity against adenovirus and hiv

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8802193-6

Format of ref document f/p: F